Published in J Gen Virol on June 02, 2010
B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies. PLoS Pathog (2011) 1.16
Murid herpesvirus-4 exploits dendritic cells to infect B cells. PLoS Pathog (2011) 1.00
Myeloid infection links epithelial and B cell tropisms of Murid Herpesvirus-4. PLoS Pathog (2012) 0.97
Herpes simplex virus 1 targets the murine olfactory neuroepithelium for host entry. J Virol (2013) 0.96
A mechanistic basis for potent, glycoprotein B-directed gammaherpesvirus neutralization. J Gen Virol (2011) 0.88
Rhadinovirus host entry by co-operative infection. PLoS Pathog (2015) 0.84
Alveolar Macrophages Are a Prominent but Nonessential Target for Murine Cytomegalovirus Infecting the Lungs. J Virol (2015) 0.83
Herpesvirus glycoproteins undergo multiple antigenic changes before membrane fusion. PLoS One (2012) 0.82
Subcapsular sinus macrophages limit acute gammaherpesvirus dissemination. J Gen Virol (2015) 0.81
Virion endocytosis is a major target for murid herpesvirus-4 neutralization. J Gen Virol (2012) 0.80
Type I Interferons and NK Cells Restrict Gammaherpesvirus Lymph Node Infection. J Virol (2016) 0.77
Type I Interferons Direct Gammaherpesvirus Host Colonization. PLoS Pathog (2016) 0.76
CD8+ T cell evasion mandates CD4+ T cell control of chronic gamma-herpesvirus infection. PLoS Pathog (2017) 0.75
Type 1 interferon signalling to dendritic cells limits Murid Herpesvirus-4 spread from the olfactory epithelium. J Virol (2017) 0.75
Crystal structure of glycoprotein B from herpes simplex virus 1. Science (2006) 5.57
Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med (2009) 5.47
Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol (2000) 4.09
Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO J (1986) 3.89
Antibody vs. HIV in a clash of evolutionary titans. Proc Natl Acad Sci U S A (2005) 3.57
The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J Virol (1995) 3.16
Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G. Science (2007) 2.97
K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. Nat Immunol (2002) 2.13
Viral interference with antigen presentation. Nat Immunol (2002) 2.05
Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands. J Virol (2000) 2.04
Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration. J Virol (1988) 1.94
Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties. Virology (2001) 1.90
Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo. J Virol (2004) 1.85
A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope. Proc Natl Acad Sci U S A (1999) 1.78
Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo. J Virol (1982) 1.69
Antibody-mediated control of persistent gamma-herpesvirus infection. J Immunol (2002) 1.59
New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins. Nucleic Acids Res (1990) 1.58
Immunological control of a murine gammaherpesvirus independent of CD8+ T cells. J Gen Virol (1999) 1.49
Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice. J Virol (2002) 1.48
Murine gammaherpesvirus-68 glycoprotein H-glycoprotein L complex is a major target for neutralizing monoclonal antibodies. J Gen Virol (2006) 1.39
Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. J Virol (1989) 1.38
Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies. J Virol (1993) 1.32
Glycosaminoglycan interactions in murine gammaherpesvirus-68 infection. PLoS One (2007) 1.31
Characterization of gamma2-human herpesvirus-8 glycoproteins gH and gL. Arch Virol (2002) 1.26
Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected mice. J Gen Virol (2006) 1.26
In vivo imaging of murid herpesvirus-4 infection. J Gen Virol (2009) 1.21
Gamma-herpesvirus latency requires T cell evasion during episome maintenance. PLoS Biol (2005) 1.20
Characterization of murine gammaherpesvirus 68 glycoprotein B. J Virol (2004) 1.19
IgG fc receptors provide an alternative infection route for murine gamma-herpesvirus-68. PLoS One (2007) 1.19
Antibodies to gp350/220 enhance the ability of Epstein-Barr virus to infect epithelial cells. J Virol (2006) 1.14
The murid herpesvirus-4 gH/gL binds to glycosaminoglycans. PLoS One (2008) 1.12
The murine gammaherpesvirus-68 gp150 acts as an immunogenic decoy to limit virion neutralization. PLoS One (2007) 1.10
Immune control of mammalian gamma-herpesviruses: lessons from murid herpesvirus-4. J Gen Virol (2009) 1.09
Murine gammaherpesvirus-68 ORF28 encodes a non-essential virion glycoprotein. J Gen Virol (2005) 1.05
Mixed infection with multiple strains of murine cytomegalovirus occurs following simultaneous or sequential infection of immunocompetent mice. J Gen Virol (2006) 1.04
Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization. J Gen Virol (1999) 1.04
Evidence for a multiprotein gamma-2 herpesvirus entry complex. J Virol (2007) 1.03
Glycoprotein B switches conformation during murid herpesvirus 4 entry. J Gen Virol (2008) 1.03
Antibody evasion by the N terminus of murid herpesvirus-4 glycoprotein B. EMBO J (2007) 1.00
The Murid Herpesvirus-4 gL regulates an entry-associated conformation change in gH. PLoS One (2008) 0.99
In vivo importance of heparan sulfate-binding glycoproteins for murid herpesvirus-4 infection. J Gen Virol (2009) 0.96
Post-exposure vaccination improves gammaherpesvirus neutralization. PLoS One (2007) 0.96
Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. J Virol (1992) 0.92
CD4+ T cells specific for a model latency-associated antigen fail to control a gammaherpesvirus in vivo. Eur J Immunol (2006) 0.90
Glycoprotein L sets the neutralization profile of murid herpesvirus 4. J Gen Virol (2009) 0.87
Anti-HHV-8/KSHV antibodies in infected individuals inhibit infection in vitro. AIDS (2004) 0.85
Antibody limits in vivo murid herpesvirus-4 replication by IgG Fc receptor-dependent functions. J Gen Virol (2009) 0.83
The amino-terminal residue of glycoprotein B is critical for neutralization of bovine herpesvirus 1. Virus Res (2005) 0.81
Herpes simplex virus type 1-vaccinia virus recombinant expressing glycoprotein B: protection from acute and latent infection. J Infect Dis (1988) 0.80
Immune response to intranasal and intraperitoneal immunization with Kaposi's sarcoma-associated herpesvirus in mice. Vaccine (2010) 0.79
Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation. EMBO J (2002) 2.23
Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo. J Virol (2004) 1.85
Viral degradation of the MHC class I peptide loading complex. Immunity (2004) 1.51
Murine gammaherpesvirus 68 lacking thymidine kinase shows severe attenuation of lytic cycle replication in vivo but still establishes latency. J Virol (2003) 1.42
Murine gammaherpesvirus-68 glycoprotein H-glycoprotein L complex is a major target for neutralizing monoclonal antibodies. J Gen Virol (2006) 1.39
Glycoprotein L disruption reveals two functional forms of the murine gammaherpesvirus 68 glycoprotein H. J Virol (2006) 1.35
Glycoprotein M is an essential lytic replication protein of the murine gammaherpesvirus 68. J Virol (2005) 1.35
Glycosaminoglycan interactions in murine gammaherpesvirus-68 infection. PLoS One (2007) 1.31
Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected mice. J Gen Virol (2006) 1.26
In vivo imaging of murid herpesvirus-4 infection. J Gen Virol (2009) 1.21
Gamma-herpesvirus latency requires T cell evasion during episome maintenance. PLoS Biol (2005) 1.20
Murine gammaherpesvirus 68 bcl-2 homologue contributes to latency establishment in vivo. J Gen Virol (2005) 1.19
Characterization of murine gammaherpesvirus 68 glycoprotein B. J Virol (2004) 1.19
IgG fc receptors provide an alternative infection route for murine gamma-herpesvirus-68. PLoS One (2007) 1.19
Forced lytic replication impairs host colonization by a latency-deficient mutant of murine gammaherpesvirus-68. J Gen Virol (2004) 1.17
Multiple functions for ORF75c in murid herpesvirus-4 infection. PLoS One (2008) 1.17
The murid herpesvirus-4 gH/gL binds to glycosaminoglycans. PLoS One (2008) 1.12
Murine gammaherpesvirus-68 inhibits antigen presentation by dendritic cells. PLoS One (2007) 1.10
The murine gammaherpesvirus-68 gp150 acts as an immunogenic decoy to limit virion neutralization. PLoS One (2007) 1.10
The murine gammaherpesvirus 68 ORF27 gene product contributes to intercellular viral spread. J Virol (2005) 1.07
A gamma-herpesvirus glycoprotein complex manipulates actin to promote viral spread. PLoS One (2008) 1.06
Murine gammaherpesvirus-68 ORF28 encodes a non-essential virion glycoprotein. J Gen Virol (2005) 1.05
Evidence for a multiprotein gamma-2 herpesvirus entry complex. J Virol (2007) 1.03
Glycoprotein B switches conformation during murid herpesvirus 4 entry. J Gen Virol (2008) 1.03
Intercellular gamma-herpesvirus dissemination involves co-ordinated intracellular membrane protein transport. Traffic (2005) 1.02
Murid herpesvirus-4 exploits dendritic cells to infect B cells. PLoS Pathog (2011) 1.00
Antibody evasion by the N terminus of murid herpesvirus-4 glycoprotein B. EMBO J (2007) 1.00
The Murid Herpesvirus-4 gL regulates an entry-associated conformation change in gH. PLoS One (2008) 0.99
An internal ribosome entry site directs translation of the murine gammaherpesvirus 68 MK3 open reading frame. J Virol (2003) 0.98
Myeloid infection links epithelial and B cell tropisms of Murid Herpesvirus-4. PLoS Pathog (2012) 0.97
Herpes simplex virus 1 targets the murine olfactory neuroepithelium for host entry. J Virol (2013) 0.96
In vivo importance of heparan sulfate-binding glycoproteins for murid herpesvirus-4 infection. J Gen Virol (2009) 0.96
Post-exposure vaccination improves gammaherpesvirus neutralization. PLoS One (2007) 0.96
Illumination of murine gammaherpesvirus-68 cycle reveals a sexual transmission route from females to males in laboratory mice. PLoS Pathog (2013) 0.94
Transcription of the murine gammaherpesvirus 68 ORF73 from promoters in the viral terminal repeats. J Gen Virol (2005) 0.94
Absence of a functional defect in CD8+ T cells during primary murine gammaherpesvirus-68 infection of I-A(b-/-) mice. J Gen Virol (2003) 0.94
Antibody evasion by a gammaherpesvirus O-glycan shield. PLoS Pathog (2011) 0.93
Bovine herpesvirus type 4 glycoprotein L is nonessential for infectivity but triggers virion endocytosis during entry. J Virol (2011) 0.91
The bovine herpesvirus 4 Bo10 gene encodes a nonessential viral envelope protein that regulates viral tropism through both positive and negative effects. J Virol (2010) 0.91
A heparan-dependent herpesvirus targets the olfactory neuroepithelium for host entry. PLoS Pathog (2012) 0.90
Murid herpesvirus-4 lacking thymidine kinase reveals route-dependent requirements for host colonization. J Gen Virol (2009) 0.90
CD4+ T cells specific for a model latency-associated antigen fail to control a gammaherpesvirus in vivo. Eur J Immunol (2006) 0.90
A gamma-herpesvirus immune evasion gene allows tumor cells in vivo to escape attack by cytotoxic T cells specific for a tumor epitope. Eur J Immunol (2002) 0.90
A single CD8+ T cell epitope sets the long-term latent load of a murid herpesvirus. PLoS Pathog (2008) 0.89
Important role for the murid herpesvirus 4 ribonucleotide reductase large subunit in host colonization via the respiratory tract. J Virol (2010) 0.89
A mechanistic basis for potent, glycoprotein B-directed gammaherpesvirus neutralization. J Gen Virol (2011) 0.88
The murine gamma-herpesvirus-68 MK3 protein causes TAP degradation independent of MHC class I heavy chain degradation. Eur J Immunol (2005) 0.88
Glycoprotein L sets the neutralization profile of murid herpesvirus 4. J Gen Virol (2009) 0.87
Protection against wild-type murine gammaherpesvirus-68 latency by a latency-deficient mutant. J Gen Virol (2004) 0.86
Murine gammaherpesvirus 68 open reading frame 11 encodes a nonessential virion component. J Virol (2005) 0.86
An essential role for the proximal but not the distal cytoplasmic tail of glycoprotein M in murid herpesvirus 4 infection. PLoS One (2008) 0.86
Comparative study of murid gammaherpesvirus 4 infection in mice and in a natural host, bank voles. J Gen Virol (2010) 0.85
Antibody limits in vivo murid herpesvirus-4 replication by IgG Fc receptor-dependent functions. J Gen Virol (2009) 0.83
Dendritic cells present lytic antigens and maintain function throughout persistent gamma-herpesvirus infection. J Immunol (2007) 0.83
Herpesvirus glycoproteins undergo multiple antigenic changes before membrane fusion. PLoS One (2012) 0.82
In vivo function of the murid herpesvirus-4 ribonucleotide reductase small subunit. J Gen Virol (2011) 0.81
Virion endocytosis is a major target for murid herpesvirus-4 neutralization. J Gen Virol (2012) 0.80
Interference with dendritic cell populations limits early antigen presentation in chronic γ-herpesvirus-68 infection. J Immunol (2010) 0.79
A gammaherpesvirus uses alternative splicing to regulate its tropism and its sensitivity to neutralization. PLoS Pathog (2013) 0.77
An in vitro system for studying murid herpesvirus-4 latency and reactivation. PLoS One (2010) 0.76
BAFF receptor deficiency limits gammaherpesvirus infection. J Virol (2014) 0.76
Glycoprotein B cleavage is important for murid herpesvirus 4 to infect myeloid cells. J Virol (2013) 0.76